JAMES PATRAS: Open Payments
NPI 1811948722 · RIVER FOREST, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 42 payments from 9 companies in 2025. Trend: 2023 $1,767 · 2024 $2,283 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $348 |
| Otsuka America Pharmaceutical, Inc. | 7 | $201 |
| Alkermes, Inc. | 5 | $113 |
| E.R. Squibb & Sons, L.L.C. | 4 | $90 |
| Lundbeck LLC | 3 | $47 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Neurocrine BioSciences, Inc. | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: VRAYLAR, REXULTI, COBENFY, ARISTADA, Auvelity, INGREZZA, LYBALVI, ABILIFY ASIMTUFII.
Industry payments across IL — which companies pay providers there.
